C07F 3/10
Mercury compounds
C07F3/10 (Mercury compounds) appears on 46 US grants and 5 published applications in this corpus.
Search patents in C07F- Granted patents
- 46
- Published applications
- 5
- Assignees
- 31
- Inventors
- 80
- Latest grant
- 28 Sep 2004
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 4 | 0 |
| 1978 | 4 | 0 |
| 1979 | 3 | 0 |
| 1980 | 4 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 3 | 0 |
| 1987 | 3 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Process for the purification of organometallic compounds or heteroatomic organic compounds with hydrogenated getter alloys28 Sep 2004US 6,797,182 B2Saes Getters S. P. A.
- Amino-and mercurio-substituted 4′,5'-dihydropsoralens and therapeutical uses thereof3 Jul 2001US 6,255,324 B1
- Single source metalloorgranic precursors to type 14-16 semiconductors28 Oct 1997US 5,681,975 ARutgers, The State University
- Radiohalogenated small molecules for protein labeling11 Mar 1997US 5,609,848 ANeoRx Corporation
- Single source metalloorganic precursors to type II-VI semiconductors18 Jun 1996US 5,527,909 ARutgers, The State University of New Jersey
- Complexes and Compounds of Mercaptophenols and Curcumin for Therapeutic Applications23 Apr 2026US 2026/0109720 A1
- In vivo stable hg-197(m) compounds, method for the production thereof and use thereof in nuclear medical diagnostics and endoradionuclide therapy (theranostics)29 Jul 2021US 2021/0228748 A1Helmholtz-Zentrum Dresden-Rossendorf E. V.
- In vivo stable hg-197(m) compounds, method for the production thereof and use thereof in nuclear medical diagnostics and endoradionuclide therapy (theranostics)5 Dec 2019US 2019/0367537 A1Helmholtz-Zentrum Dresden-Rossendorf E. V.
- Substituted 5-(bicyclo[4.1.0]hept-3-en-2-yl)penta-2,4-dienes and 5-(bicyclo[4.1.0]hept-3-en-2-yl)pent-2-ene-4-ines as active agents against abiotic stresses in plants20 Feb 2014US 2014/0051577 A1
- Process for the purification of organometallic compounds or heteroatomic organic compounds with hydrogenated getter alloys27 Feb 2003US 2003/0038082 A1Saes Getters S.P.A.
Most cited
By later US patents
- Fungicidal composition and method containing 2-amino-pyrimidines47US 3,980,781 AImperial Chemical Industries PLC · 1976
- Hydrocarbon-substituted analogs of phosphine and arsine, particularly for metal organic chemical vapor deposition30US 4,734,514 AMorton Thiokol, Inc. · 1988
- Substituted 2-aminomethyl-6-iodophenols26US 4,029,816 AMerck & Co., Inc. · 1977
- Single source metalloorgranic precursors to type 14-16 semiconductors25US 5,681,975 ARutgers, The State University · 1997
- Production of 5-nitrotetrazole salts21US 4,094,879 AThe Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland · 1978